Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Annals of Allergy, Asthma and Immunology is Scopus-indexed (Q1, CiteScore 7.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by American College of Allergy, Asthma and Immunology.
Checked against the index lists dated .
ISSN 1081-1206Verify ISSN ↗1534-4436Verify ISSN ↗
Publisher: American College of Allergy, Asthma and Immunology
Cost to publish: About US$3,400 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 26 / 165 | 84th | Q1 |
| Immunology and Allergy | 64 / 234 | 72nd | Q2 |
| Immunology | 71 / 243 | 70th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1995–present, best quartile Q1, CiteScore 7.2.
Annals of Allergy, Asthma and Immunology is Q1 in Pulmonary and Respiratory Medicine (rank 26 of 165), Q2 in Immunology and Allergy (rank 64 of 234) and Q2 in Immunology (rank 71 of 243), by CiteScore 2025.
Annals of Allergy, Asthma and Immunology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.2, which places it in quartile Q1 at the 84th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.191, quartile Q1, with an H-index of 137.
The publisher lists an article processing charge of about US$3,400 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Annals of Allergy, Asthma and Immunology is published by American College of Allergy, Asthma and Immunology. Its print ISSN is 1081-1206 and its online ISSN is 1534-4436.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Annals of Allergy, Asthma and Immunology has an h-index of 148 and a 2-year mean of 1.18 citations per paper (OpenAlex). Its Scopus CiteScore is 7.2, quartile Q1. On 2-year citations it ranks #89 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Annals of Allergy, Asthma and Immunology published 1,071 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from United States (70.3%), China (4.7%) and Poland (3.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.